209 related articles for article (PubMed ID: 16247334)
21. Activation of spinal opioid receptors contributes to hypotension after hemorrhage in conscious rats.
Ang KK; McRitchie RJ; Minson JB; Llewellyn-Smith IJ; Pilowsky PM; Chalmers JP; Arnolda LF
Am J Physiol; 1999 May; 276(5):H1552-8. PubMed ID: 10330238
[TBL] [Abstract][Full Text] [Related]
22. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
[TBL] [Abstract][Full Text] [Related]
23. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
[TBL] [Abstract][Full Text] [Related]
24. Antitussive effect of dihydroetorphine in mice.
Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1994 Aug; 260(2-3):257-9. PubMed ID: 7988653
[TBL] [Abstract][Full Text] [Related]
25. The anticonvulsant effects of DADLE are primarily mediated by activation of delta opioid receptors: interactions between delta and mu receptor antagonists.
Tortella FC; Robles L; Holaday JW
Life Sci; 1985 Aug; 37(6):497-503. PubMed ID: 2991684
[TBL] [Abstract][Full Text] [Related]
26. Central inhibition of opioid receptor subtypes and its effect on haemorrhagic hypotension in conscious sheep.
Frithiof R; Eriksson S; Rundgren M
Acta Physiol (Oxf); 2007 Sep; 191(1):25-34. PubMed ID: 17550406
[TBL] [Abstract][Full Text] [Related]
27. Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors.
Stanojević S; Vujić V; Mitić K; Kustrimović N; Kovacević-Jovanović V; Miletić T; Dimitrijević M
Neuropeptides; 2008 Apr; 42(2):147-58. PubMed ID: 18237778
[TBL] [Abstract][Full Text] [Related]
28. Mu and delta opioid receptor interactions in a rat model of drug induced seizures.
Tortella FC; Holaday JW
Proc West Pharmacol Soc; 1984; 27():435-7. PubMed ID: 6093137
[No Abstract] [Full Text] [Related]
29. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
Walker BM; Koob GF
Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
[TBL] [Abstract][Full Text] [Related]
30. Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Silva RM; Grossman HC; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2002 May; 301(2):513-8. PubMed ID: 11961051
[TBL] [Abstract][Full Text] [Related]
31. Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice.
Lesscher HM; Bailey A; Burbach JP; Van Ree JM; Kitchen I; Gerrits MA
Eur J Neurosci; 2003 Mar; 17(5):1006-12. PubMed ID: 12653976
[TBL] [Abstract][Full Text] [Related]
32. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
Matsuzawa S; Suzuki T; Misawa M; Nagase H
Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
[TBL] [Abstract][Full Text] [Related]
33. Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes.
Perez L; Lysle DT
J Neuroimmunol; 1997 Nov; 79(2):101-12. PubMed ID: 9394782
[TBL] [Abstract][Full Text] [Related]
34. Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats.
Leventhal L; Bodnar RJ
Brain Res; 1996 Nov; 741(1-2):300-8. PubMed ID: 9001736
[TBL] [Abstract][Full Text] [Related]
35. The dynamic relationship between mu and kappa opioid receptors in body temperature regulation.
Chen X; McClatchy DB; Geller EB; Tallarida RJ; Adler MW
Life Sci; 2005 Dec; 78(4):329-33. PubMed ID: 16257420
[TBL] [Abstract][Full Text] [Related]
36. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
37. Comparison of cardiovascular effects of mu- and delta-opioid receptor antagonists in dogs with congestive heart failure.
Imai N; Kashiki M; Woolf PD; Liang CS
Am J Physiol; 1994 Sep; 267(3 Pt 2):H912-7. PubMed ID: 8092295
[TBL] [Abstract][Full Text] [Related]
38. Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.
Evans RG; Ludbrook J; Van Leeuwen AF
J Physiol; 1989 Dec; 419():15-31. PubMed ID: 2559974
[TBL] [Abstract][Full Text] [Related]
39. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
40. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
